ANXA1 and COVID-19: Additionally, recent studies have indicated that secreted ANXA1 in plasma may function as a circulating biomarker for the diagnosis of COVID-19 and colorectal cancer,47,48 thus suggesting its prospective roles in the diagnosis of PDAC.